Point of Care Diagnostics Market Size is valued at USD 15.59 Billion in 2024 and is predicted to reach USD 34.68 Billion by the year 2034 at a 8.4% CAGR during the forecast period for 2025-2034.
Point-Of-Care diagnostic devices are used for early and quick diagnosis of diseases. These techniques are highly sensitive, cost-effective, and produce immediate results. Point-of-care diagnostics have many advantages in the physician’s office, home healthcare, research laboratory, and in the hospital. One of the major factors responsible for the growth of this market are the rising prevalence of chronic and infectious diseases all over the world. Moreover, the COVID-19 pandemic has significantly affected the point of care diagnostics market. An increasing number of COVID-19 patients forcing the healthcare industry to develop rapid and advance testing tools, driving the opportunities for POC market.
High prevalence of infectious diseases, rising human health issues, need for rapid diagnostics, lack of advanced technologies in the diagnostic labs, growing preference for home healthcare, new inventions and innovations by key players, changes in lifestyle patterns, and increasing healthcare expenditure will create more opportunities to expand the point of care diagnostics market during the forecast period.
The point of care diagnostics market can be segmented on the basis of products, Platform, mode of purchase, technology, sample type, end-users, and region. Firstly, the Product segment consists of Glucose Monitoring Products (Strips, Meters, Lancets & Lancing Devices), Cardiometabolic Monitoring Products (Cardiac Marker Testing, Blood Gas/Electrolyte Testing, HbA1c Testing), Infectious Disease Testing Products (Respiratory Infection Testing [Influenza, Tuberculosis, Others], Healthcare-Associated Infection Testing, Tropical Disease Testing, Sexually Transmitted Disease Testing [HIV, Hepatitis, Syphilis, HPV, Chlamydia, Gonorrhea, Herpes], Clostridium difficile Infection Testing, Other Infectious Disease Testing), Coagulation Monitoring Products (PT/INR, ACT/APTT), Pregnancy & Fertility Testing Products (Pregnancy, Fertility), Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Thyroid-Stimulating Hormone Testing Products, Fecal Occult Testing Products, Other Products). According to the Mode of Purchase, the market is further divided into Prescription-Based Testing Products, OTC Testing Products. Whereas, By Technology, the overall market is again subdivided into Biochemistry, Immunoassays, Molecular Diagnostics (RT-PCR, INAAT). The Sample Type segment comprises Blood Samples, Nasal & Oropharyngeal Swabs, Urine Samples, Other Samples. Whereas, the End User segment includes Home Care Settings & Self-Testing, Clinical Laboratories, Hospitals/Critical Care/Urgent Care Centers, Ambulatory Care Facilities & Physician Offices, and Other End Users.
The glucose monitoring category constitutes the largest portion of the point-of-care diagnostics market, primarily due to the rising prevalence of diabetes globally. The global prevalence of diabetes among millions of patients underscores the necessity for continuous glucose monitoring via regular blood glucose assessments, hence supporting the demand for reliable, accurate, and user-friendly glucose testing instruments. The improvement of technology, precision, user-friendliness, and cost are pivotal elements that enhance the adoption rates of glucose monitoring systems by both patients and healthcare practitioners.
In 2024, biochemistry constituted the predominant segment of the point-of-care diagnostics market. Biochemical markers, including glucose, electrolytes, and lipids, must be assessed for chronic disorders such as kidney diseases, diabetes, and cardiovascular disease, which create substantial demand for biochemistry technology. Biochemistry-based point-of-care devices are favored for their simplicity, rapidity, and cost-efficiency in clinical and home-care environments. Furthermore, smaller analyzers enhanced the accuracy and utility of the items, hence augmenting their demand.
In 2024, North America led the market because to its robust healthcare infrastructure and accessibility to advanced diagnostic technology. Lifestyle diseases, such diabetes, are prevalent and have therefore heightened the demand for immediate, point-of-care testing options. The region benefits from robust government programs for research and product innovation, as well as regulatory clearances for the development of innovative point-of-care diagnostic technologies with extensive uptake.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 15.59 Billion |
|
Revenue Forecast In 2034 |
USD 34.68 Billion |
|
Growth Rate CAGR |
CAGR of 8.4% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Mode of purchase, Technology, Sample type, By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Abbott Laboratories, Nova Biomedical, Chembio Diagnostic Systems, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc, Werfenlife, S.A., Johnson & Johnson Services, Inc., Hoffmann-La Roche Ltd., Sekisui Chemical Co. Ltd., Dickinson, And Company (Bd), Quidel Corporation, Siemens Ag, Trinity Biotech, Accubiotech Co., Ltd., and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Point of Care Diagnostics Market Snapshot
Chapter 4. Global Point of Care Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Point of Care Diagnostics Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on POINT OF CARE DIAGNOSTICS MARKET Industry Trends
Chapter 5. Point of Care Diagnostics Market Segmentation 1: By Products, Estimates & Trend Analysis
5.1. Market Share by Products, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Products:
5.2.1. Glucose Monitoring Products
5.2.1.1. Glucose Monitoring Strips
5.2.1.2. Glucose Monitoring Meters
5.2.1.3. Glucose Monitoring Lancets & Lancing Devices
5.2.2. Cardiometabolic Monitoring Products
5.2.2.1. Cardiac Marker Testing Products
5.2.2.2. Blood Gas/Electrolyte Testing Products
5.2.2.3. HbA1c Testing Products
5.2.3. Infectious Disease Testing Products
5.2.3.1. Respiratory Infection Testing Products
5.2.3.1.1. Influenza Testing Products
5.2.3.1.2. Tuberculosis
5.2.3.1.3. Other Respiratory Infections
5.2.3.2. Healthcare-Associated Infection Testing Products
5.2.3.3. Tropical Disease Testing Products
5.2.3.4. Sexually Transmitted Disease Testing Products
5.2.3.4.1. HIV Testing Products
5.2.3.4.2. Hepatitis Testing Products
5.2.3.4.3. Syphilis Testing Products
5.2.3.4.4. Human Papillomavirus Testing Products
5.2.3.4.5. Chlamydia trachomatis Testing Products
5.2.3.4.6. Neisseria gonorrhoeae Testing Products
5.2.3.4.7. Herpes Simplex Virus Testing Products
5.2.3.5. Clostridium difficile Infection Testing Products
5.2.3.6. Other Infectious Disease Testing Products
5.2.4. Coagulation Monitoring Products
5.2.4.1. PT/INR Testing Products
5.2.4.2. ACT/APTT Testing Products
5.2.5. Pregnancy & Fertility Testing Products
5.2.5.1. Pregnancy Testing Products
5.2.5.2. Fertility Testing Products
5.2.6. Tumor/Cancer Marker Testing Products
5.2.7. Urinalysis Testing Products
5.2.8. Cholesterol Testing Products
5.2.9. Hematology Testing Products
5.2.10. Drugs-of-Abuse Testing Products
5.2.11. Thyroid-Stimulating Hormone Testing Products
5.2.12. Fecal Occult Testing Products
5.2.13. Other Products
Chapter 6. Point of Care Diagnostics Market Segmentation 2: By Mode of Purchase, Estimates & Trend Analysis
6.1. Market Share by Mode of Purchase, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Mode of Purchase:
6.2.1. Prescription-Based Testing Products
6.2.2. Over-the-Counter (OTC) Testing Product
Chapter 7. Point of Care Diagnostics Market Segmentation 3: By Technology, Estimates & Trend Analysis
7.1. Market Share by Technology, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
7.2.1. Biochemistry
7.2.2. Immunoassays
7.2.3. Molecular Diagnostics
7.2.3.1. RT-PCR
7.2.3.2. INAAT
Chapter 8. Point of Care Diagnostics Market Segmentation 4: By Sample Type, Estimates & Trend Analysis
8.1. Market Share by Sample Type, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Sample Type:
8.2.1. Blood Samples
8.2.2. Nasal & Oropharyngeal Swabs
8.2.3. Urine Samples
8.2.4. Other Samples
Chapter 9. Point of Care Diagnostics Market Segmentation 5: By End-users, Estimates & Trend Analysis
9.1. Market Share by End-users, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-users:
9.2.1. Home Care/Self Testing
9.2.2. Physician offices & Outpatient/Ambulatory Care Settings
9.2.3. Hospitals
9.2.4. Research Laboratories
Chapter 10. Point of Care Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Point of Care Diagnostics Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.2.3. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.2.4. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.2.5. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.2.6. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.3. Europe
10.3.1. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.3.3. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.3.4. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.3.5. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.3.6. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.4.3. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.4.4. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.4.5. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts By Sample Type, 2021-2034
10.4.6. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.5. Latin America
10.5.1. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.5.3. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.5.4. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.5.5. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.5.6. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.6.3. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.6.4. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.6.5. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.6.6. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Dickinson, And Company (Bd)
11.2.3. Chembio Diagnostic Systems, Inc.
11.2.4. Danaher Corporation
11.2.5. Ekf Diagnostics Holdings Plc
11.2.6. Werfenlife, S.A.
11.2.7. Johnson & Johnson Services, Inc.
11.2.8. Nova Biomedical
11.2.9. Hoffmann-La Roche Ltd.
11.2.10. Sekisui Chemical Co. Ltd.
11.2.11. Quidel Corporation
11.2.12. Siemens Ag
11.2.13. Trinity Biotech
11.2.14. Accubiotech Co., Ltd.
11.2.15. Other Key Players.
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Products
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Mode of Purchase
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Technology
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Sample Type
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on End-users
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Region
North America Point of Care Diagnostics Market Revenue (US$ Billion) by Country
Europe Point of Care Diagnostics Market Revenue (US$ Billion) by Country
Asia Pacific Point of Care Diagnostics Market Revenue (US$ Billion) by Country
Latin America Point of Care Diagnostics Market Revenue (US$ Billion) by Country
Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Billion) by Country
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
